How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage
暂无分享,去创建一个
Y. Izumiya | M. Yoshiyama | A. Shibata | H. Ishikawa | H. Hayashi | Hirotoshi Ishikawa | Atsushi Shibata | Yasuhiro Izumiya
[1] Sanjiv J. Shah,et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. , 2021, Circulation. Cardiovascular imaging.
[2] A. Farioli,et al. Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies , 2020, European journal of heart failure.
[3] C. Rapezzi,et al. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. , 2019, Circulation. Heart failure.
[4] Sanjiv J. Shah,et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization , 2019, Journal of Nuclear Cardiology.
[5] R. Falk,et al. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. , 2019, JACC. Heart failure.
[6] S. Shiraishi,et al. Combination of Commonly Examined Parameters Is a Useful Predictor of Positive 99 mTc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis. , 2019, Circulation journal : official journal of the Japanese Circulation Society.
[7] L. Køber,et al. Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes. , 2019, Journal of the American College of Cardiology.
[8] C. Hengstenberg,et al. Mechanisms of heart failure in transthyretin vs. light chain amyloidosis. , 2019, European heart journal cardiovascular Imaging.
[9] P. Kellman,et al. Native T1 and Extracellular Volume in Transthyretin Amyloidosis. , 2019, JACC. Cardiovascular imaging.
[10] M. Cameli,et al. Speckle tracking echocardiography in cardiac amyloidosis , 2019, Heart Failure Reviews.
[11] H. Katus,et al. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? , 2019, Clinical Research in Cardiology.
[12] A. Jaffe,et al. Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel. , 2019, Journal of the American College of Cardiology.
[13] D. Phelan,et al. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. , 2018, Journal of the American College of Cardiology.
[14] M. Henein,et al. Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis , 2018, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[15] Y. Izumiya,et al. Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis , 2017, ESC heart failure.
[16] F. Ruberg,et al. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment. , 2018, Trends in cardiovascular medicine.
[17] M. P. van den Berg,et al. Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide. , 2018, The American journal of cardiology.
[18] M. Leon,et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement , 2017, European heart journal.
[19] S. Solomon,et al. Left atrial structure and function in cardiac amyloidosis , 2017, European heart journal cardiovascular Imaging.
[20] R. Falk,et al. Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis , 2017, JAMA.
[21] P. Kellman,et al. Magnetic Resonance in Transthyretin Cardiac Amyloidosis. , 2017, Journal of the American College of Cardiology.
[22] M. Ugander,et al. Cardiac Amyloidosis Shows Decreased Diastolic Function as Assessed by Echocardiographic Parameterized Diastolic Filling. , 2017, Ultrasound in medicine & biology.
[23] C. Rapezzi,et al. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths , 2017, European heart journal.
[24] P. Elliott,et al. Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis , 2017, Circulation.
[25] A. Petrie,et al. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis , 2017, European heart journal.
[26] Clarissa M Koch,et al. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model , 2017, JAMA cardiology.
[27] J. Goldsmith,et al. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. , 2016, JAMA cardiology.
[28] A. Dispenzieri,et al. Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System. , 2016, Journal of the American College of Cardiology.
[29] James C Moon,et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis , 2016, Circulation.
[30] D. Mele,et al. Longitudinal strain of left ventricular basal segments and E/e′ ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study , 2016, Echocardiography.
[31] M. Skinner,et al. Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study , 2016, Circulation.
[32] P. Kellman,et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2015, Circulation.
[33] E. González-López,et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. , 2015, European heart journal.
[34] X. Chen,et al. Early Impairment of Cardiac Function and Asynchronization of Systemic Amyloidosis with Preserved Ejection Fraction Using Two‐Dimensional Speckle Tracking Echocardiography , 2015, Echocardiography.
[35] H. Jono,et al. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis , 2015, Modern Pathology.
[36] J. Goldsmith,et al. Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis. , 2014, The American journal of cardiology.
[37] Adelaide M. Arruda-Olson,et al. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. , 2014, The American journal of cardiology.
[38] S. K. White,et al. Native T1 mapping in transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.
[39] A. Petrie,et al. Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome , 2013, Journal of the American Heart Association.
[40] M. Robson,et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.
[41] M. Maurer,et al. 99mTc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses , 2013, Circulation. Cardiovascular imaging.
[42] James D. Thomas,et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis , 2012, Heart.
[43] H. Jono,et al. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study , 2011, Modern Pathology.
[44] J. Koyama,et al. Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis , 2011, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[45] T. Imaeda,et al. High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly. , 2011, Human pathology.
[46] M. Schieber,et al. Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance , 2010, Circulation.
[47] Matthew W. Martinez,et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. , 2010, JACC. Cardiovascular imaging.
[48] M. Desai,et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. , 2009, JACC. Cardiovascular imaging.
[49] F. Salvi,et al. Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types , 2009, Circulation.
[50] W. Hoffmann,et al. Complication Rate of Right Ventricular Endomyocardial Biopsy via the Femoral Approach: A Retrospective and Prospective Study Analyzing 3048 Diagnostic Procedures Over an 11-Year Period , 2008, Circulation.
[51] S. Neubauer,et al. Evaluation and management of the cardiac amyloidosis. , 2007, Journal of the American College of Cardiology.
[52] B. Sivakumar,et al. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis. , 2004, Biochimica et biophysica acta.
[53] Richard E Thompson,et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. , 2004, Journal of the American College of Cardiology.
[54] G. Sobue,et al. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. , 2002, Archives of neurology.
[55] M. Hiroe,et al. National survey of the use of endomyocardial biopsy in Japan. , 1998, Japanese circulation journal.
[56] J. Seward,et al. M‐mode and Two‐dimensional Echocardiographic Features in Cardiac Amyloidosis , 1981, Circulation.